OrbiMed’s Cogentix Medical, Inc. CGNT Stock Holding History

OrbiMed’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-878,145	Closed	-$1.6M	–	148
2016 Q3	$1.6M	Sell	878,145 -112,600	-11%	-$146K	0.02%	126
2016 Q2	$953K	Hold	990,745	–	–	0.01%	127
2016 Q1	$1.09M	Hold	990,745	–	–	0.01%	136
2015 Q4	$1.28M	Hold	990,745	–	–	0.01%	123
2015 Q3	$1.23M	Hold	990,745	–	–	0.01%	128
2015 Q2	$1.6M	Buy	+990,745	New	+$1.62M	0.01%	133

Other funds holding CGNT

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

OrbiMed's CGNT Position: Q4 2016 in Review

OrbiMed sold out of Cogentix Medical, Inc. (CGNT) in Q4 2016, closing a stake of 878,145 shares — an estimated $1.6M sold.

OrbiMed first reported a position in CGNT in Q2 2015 and held it in 6 quarters. The position peaked at $1.6M in Q2 2015. 37 funds tracked by Wall St. Rank hold CGNT as of Q4 2016.

OrbiMed reported no remaining Cogentix Medical, Inc. position as of Q4 2016 after selling out during the quarter.
OrbiMed sold 878,145 Cogentix Medical, Inc. shares in Q4 2016, an estimated $1.6M.
OrbiMed first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 6 quarters.
OrbiMed's Cogentix Medical, Inc. position peaked at $1.6M in Q2 2015.
37 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q4 2016.

Based on OrbiMed's 13F filing for Q4 2016, filed 14 Feb 2017.